Parallel Advisors, LLC Nkarta, Inc. Transaction History

Parallel Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 03, 2023	BUY	$5.14 - $14.35 $61 - $172	12 Added 38.71%	43 $0
Q3 2022 Nov 10, 2022	BUY	$12.27 - $18.39 $380 - $570	31 New	31 $0
Q1 2022 Apr 28, 2022	SELL	$8.66 - $14.99 $571 - $989	-66 Closed	0 $0
Q4 2021 Jan 20, 2022	BUY	$12.79 - $26.88 $179 - $376	14 Added 26.92%	66 $1,000
Q3 2021 Nov 02, 2021	BUY	$26.67 - $38.76 $1,386 - $2,015	52 New	52 $1,000

129

66.5M

173K

20K

Ticker NKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,656,800
Market Cap $127M
Description
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Parallel Advisors, LLC with notifications on news.